The Progression of Vaccine Candidates will be highlighted during Targeting Ebola Congress 2015


In view of the current epidemic, the WHO has identified the progression of vaccine candidates currently in development as an urgent public health need. Several candidate vaccines are available. Prime/boost vaccine approaches are promising, as they may provide protection against Ebola infection that is of longer duration.

Design and implementation of Phase I, II, or III clinical development of vaccine candidates, including prime boost combinations against Ebola virus disease (Zaire), to start in early 2015.

 

During Ebola Meeting, we will discuss about the vaccine candidates available and the ability to roll out clinical trial vaccination programmes in EU / Africa, and how to conduct studies in areas where Ebola virus disease is endemic.

MANUFACTURING CAPABILITY

In view of the current epidemic, the WHO has identified the progression of vaccine candidates currently in development as an urgent public health need. Because Ebola vaccines are recombinant adenovirus or other viral-based vaccines and need to be produced in facilities meeting an appropriate biosafety level, manufacturing the quantity of vaccine doses necessary for large-scale clinical testing and that can be thereafter urgently deployed represents a major challenge. All these subtle factors will be discussed during Targeting Ebola 2015.

 

STABILITY OF VACCINES DURING TRANSPORT AND STORAGE

Currently available vaccine candidates need to be stored and transported at low temperature to maintain activity. Maintaining these conditions for deploying the vaccine in the areas targeted for vaccination can be challenging.

During Paris Ebola 2015 meeting, we will highlight how to develop tools and technologies to be able to distribute current Ebola vaccine candidates utilising existing vaccine deployment infrastructure while taking into account current stability features (e.g. the need for low temperature) and also taking into account real-world field conditions and the health systems context.

 

For more information: www.targeting-ebola.com

TARGETING EBOLA WORLD CONGRESS WAS A HUGE SUCCESS